Literature DB >> 11863242

Cognitive therapy versus interoceptive exposure as treatment of panic disorder without agoraphobia.

Arnoud Arntz1.   

Abstract

Cognitive therapy (CT) and interoceptive exposure (IE) as treatments of panic disorder without agoraphobia were compared in a sample of 69 patients, randomly allocated to condition. There were no significant differences between treatments as to reductions in panic frequency, daily anxiety levels and a composite questionnaire score, at posttest after the 12-session treatment, and at both follow-ups (4 weeks, 6 months). In both conditions, high percentages of patients were panic free at post and follow-up tests (range 75-92%). Although the reduction in idiosyncratic beliefs about the catastrophic nature of bodily sensations was equally strong in both conditions, post-treatment beliefs correlated strongly with symptoms at post and follow-up tests in the CT condition, but not in the IE condition. Reduction of beliefs may be essential in CT, but not in IE. This suggests that the two treatments utilize different change mechanisms.

Entities:  

Mesh:

Year:  2002        PMID: 11863242     DOI: 10.1016/s0005-7967(01)00014-6

Source DB:  PubMed          Journal:  Behav Res Ther        ISSN: 0005-7967


  10 in total

Review 1.  Interoception in Psychiatric Disorders: A Review of Randomized, Controlled Trials with Interoception-Based Interventions.

Authors:  Nayla M Khoury; Jacqueline Lutz; Zev Schuman-Olivier
Journal:  Harv Rev Psychiatry       Date:  2018 Sep/Oct       Impact factor: 3.732

2.  Processes of therapeutic change: Results from the Cornell-Penn Study of Psychotherapies for Panic Disorder.

Authors:  Jacques P Barber; Barbara Milrod; Robert Gallop; Nili Solomonov; Marie G Rudden; Kevin S McCarthy; Dianne L Chambless
Journal:  J Couns Psychol       Date:  2020-03

3.  Differential effects of alliance and techniques on Panic-Specific Reflective Function and misinterpretation of bodily sensations in two treatments for panic.

Authors:  Nili Solomonov; Fredrik Falkenström; Bernard S Gorman; Kevin S McCarthy; Barbara Milrod; Marie G Rudden; Dianne L Chambless; Jacques P Barber
Journal:  Psychother Res       Date:  2019-03-01

4.  Self-guided digital treatment with virtual reality for panic disorder and agoraphobia: a study protocol for a randomized controlled trial.

Authors:  Jari Planert; Alla Machulska; Anne-Sophie Hildebrand; Kati Roesmann; Esra Otto; Tim Klucken
Journal:  Trials       Date:  2022-05-21       Impact factor: 2.728

Review 5.  Efficacy of exposure versus cognitive therapy in anxiety disorders: systematic review and meta-analysis.

Authors:  Dennis Ougrin
Journal:  BMC Psychiatry       Date:  2011-12-20       Impact factor: 3.630

6.  Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: specificity and effectiveness.

Authors:  Kiyoe Lee; Yumiko Noda; Yumi Nakano; Sei Ogawa; Yoshihiro Kinoshita; Tadashi Funayama; Toshiaki A Furukawa
Journal:  BMC Psychiatry       Date:  2006-08-16       Impact factor: 3.630

7.  A non-linear dynamical approach to belief revision in cognitive behavioral therapy.

Authors:  David Kronemyer; Alexander Bystritsky
Journal:  Front Comput Neurosci       Date:  2014-05-15       Impact factor: 2.380

Review 8.  Catastrophic misinterpretation of bodily sensations and external events in panic disorder, other anxiety disorders, and healthy subjects: A systematic review and meta-analysis.

Authors:  Barnabas Ohst; Brunna Tuschen-Caffier
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

9.  Cognitive behavior therapy in the treatment of panic disorder.

Authors:  M Manjula; V Kumariah; P S D V Prasadarao; R Raguram
Journal:  Indian J Psychiatry       Date:  2009-04       Impact factor: 1.759

Review 10.  Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis.

Authors:  Alessandro Pompoli; Toshi A Furukawa; Hissei Imai; Aran Tajika; Orestis Efthimiou; Georgia Salanti
Journal:  Cochrane Database Syst Rev       Date:  2016-04-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.